Exploring Analyst Estimates for Haemonetics (HAE) Q4 Earnings, Beyond Revenue and EPSZacks Investment Research • 05/06/24
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024PRNewsWire • 04/10/24
Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN CartridgePRNewsWire • 04/04/24
Haemonetics (HAE) Crossed Above the 200-Day Moving Average: What That Means for InvestorsZacks Investment Research • 03/29/24
Haemonetics (HAE) Recently Broke Out Above the 50-Day Moving AverageZacks Investment Research • 03/11/24
Haemonetics to Present at Raymond James 45th Annual Institutional Investors ConferencePRNewsWire • 02/21/24
Haemonetics to Present at Citi's 2024 Unplugged Medtech and Life Sciences Access DayPRNewsWire • 02/21/24
Haemonetics 3rd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations WebsitePRNewsWire • 02/08/24
Haemonetics (HAE) Q3 Earnings Preview: What You Should Know Beyond the Headline EstimatesZacks Investment Research • 02/05/24
Is Haemonetics (HAE) a Solid Growth Stock? 3 Reasons to Think "Yes"Zacks Investment Research • 01/31/24
Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2024 Results: February 8, 2024PRNewsWire • 01/11/24